Rocket Lab (NASDAQ:RKLB) Shares Down 7.4% – What’s Next?

Posted by Brian Himes on Nov 1st, 2026

Rocket Lab Corporation (NASDAQ:RKLB – Get Free Report)’s stock price traded down 7.4% during mid-day trading on Friday. The company traded as low as $53.19 and last traded at $54.73. Approximately 16,426,892 shares changed hands during mid-day trading, a decline of 28% from the average daily volume of 22,760,232 shares. The stock had previously closed at $59.10.

More Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay

Analysts Set New Price Targets

Several research analysts have commented on the stock. Citigroup restated a “market outperform” rating on shares of Rocket Lab in a research report on Friday, October 16th. Wall Street Zen downgraded Rocket Lab from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Needham & Company LLC reiterated a “buy” rating and issued a $120.00 price target on shares of Rocket Lab in a research note on Friday, October 16th. Berenberg Bank began coverage on Rocket Lab in a report on Wednesday, September 2nd. They set a “buy” rating and a $83.00 price target for the company. Finally, TD Cowen restated a “buy” rating and set a $90.00 price objective on shares of Rocket Lab in a research report on Thursday, October 15th. Three research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Rocket Lab currently has an average rating of “Moderate Buy” and a consensus target price of $102.05.

View Our Latest Research Report on RKLB

Rocket Lab Stock Down 7.4%

The company has a market capitalization of $32.75 billion, a P/E ratio of -202.70 and a beta of 2.93. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The firm’s fifty day moving average is $64.23 and its 200-day moving average is $79.93.

Rocket Lab (NASDAQ:RKLB – Get Free Report) last released its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). The company had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. As a group, equities research analysts predict that Rocket Lab Corporation will post -0.20 EPS for the current year.

Insider Activity

In other news, insider Frank Klein sold 35,558 shares of the company’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $66.61, for a total transaction of $2,368,518.38. Following the completion of the transaction, the insider directly owned 925,737 shares in the company, valued at approximately $61,663,341.57. This represents a 3.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Agostino Ricupati sold 669 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $46,582.47. Following the transaction, the chief accounting officer owned 26,863 shares of the company’s stock, valued at $1,870,470.69. This trade represents a 2.43% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 400,749 shares of company stock valued at $26,964,474. 8.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Rocket Lab

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in shares of Rocket Lab during the second quarter worth about $4,124,970,000. Katamaran Capital LLP increased its stake in shares of Rocket Lab by 86.2% in the first quarter. Katamaran Capital LLP now owns 19,808 shares of the rocket manufacturer’s stock valued at $1,272,000 after buying an additional 9,172 shares during the period. Y.D. More Investments Ltd bought a new position in Rocket Lab in the 1st quarter valued at approximately $642,000. Swiss National Bank raised its holdings in Rocket Lab by 17.8% in the 1st quarter. Swiss National Bank now owns 1,410,930 shares of the rocket manufacturer’s stock valued at $90,610,000 after buying an additional 212,700 shares during the last quarter. Finally, Bank of Nova Scotia raised its holdings in Rocket Lab by 149.8% in the 1st quarter. Bank of Nova Scotia now owns 49,957 shares of the rocket manufacturer’s stock valued at $3,209,000 after buying an additional 29,956 shares during the last quarter. Institutional investors own 71.78% of the company’s stock.

Rocket Lab Company Profile

(Get Free Report)

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.